您所在的位置:首页 --> 研究报告 --> 医药产业
 

血液和淋巴系统血小板减少症或先天性血小板减少性紫癜治疗报告——Blood and Lymphatic System Thrombocytopenia or Idiopathic Thrombocytopenic Purpura Therapy Area Pipeline Report

纸介版价格:---美元 电子版价格:1495美元 纸介版+电子版价格: --- 美元
字数:---万 页数:190 图表数:
联系方式: 010-82600893,82601561/2/3 完成日期:2010-3-10
关键字:血液和淋巴系统|血小板减少症|紫癜|治疗|Blood and Lymphatic System|Thrombocytopenia|Purpura|Therapy 购买报告

2010-1-6

摘要

Life Science Analytics', Thrombocytopenia or Idiopathic Thrombocytopenic Purpura Therapy Area Pipeline Report contains detailed information on the thrombocytopenia or idiopathic thrombocytopenic purpura drug pipeline. This report provides insight into the pipeline status of thrombocytopenia or idiopathic thrombocytopenic purpura drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date. 

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.

Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.

Key benefits

• Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
• Keep track of your competitors and partners by better understanding their product pipeline.
• Monitor a company’s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
• Maintain a critical competitive advantage.

目录

Epidemiology Report
% of Products by Phase of Development
No. of Products by Phase of Development
Marketed Products vs. Pipeline Products
Company Overview - Pipeline Projects
Legend 
--Top 5 Companies in Early Stage Thrombocytopenia or Idiopathic
Thrombocytopenic Purpura Products
--Top 5 Companies in Late Stage Thrombocytopenia or Idiopathic Thrombocytopenic Purpura Products
--Top 5 Companies in Marketed Thrombocytopenia or Idiopathic Thrombocytopenic Purpura Products
Patent Expirations
Upcoming Milestones
Product Sales
Full Pipeline View
--Product Details : Unknown/Research
--Product Details : Pre Clinical
--Product Details : Phase I
--Product Details : Phase II
--Product Details : Phase III
--Product Details : Pending Approval
--Product Details : On the Market
News Updates
--Product Updates
--Regulatory

 



 
     | 首页 | 联系我们 | 关于我们  |  本站动态 | 用户论坛 | 如何购买 |  版权声明 |